Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Magnesium Oxide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 14 USDMF, 1 CEP/COS, 15 JDMF, 1 EU WC, 2 KDMF, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers, 6 FDA Orange Book, 3 Europe, 5 Canada, 21 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 10 Rochem International Inc, 19 SPI Pharma, 24 DKSH, 1 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 34 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 19 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 46 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 38 Solubilizers, 37 Taste Masking, 36 Direct Compression, 34 Controlled & Modified Release, 31 Parenteral, 30 Granulation, 26 Film Formers & Plasticizers, 24 Topical, 21 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 16 Co-Processed Excipients, 15 Emulsifying Agents, 13 Rheology Modifiers, 9 Empty Capsules, 8 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 9 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices

3 Regulatory FDF Prices

MARKET PLACE

12 APIs, 2 FDF Dossiers, 3 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/03/2025	Kyowa Hakko Bio	Japan	Kyowa Chemical Industry Co., Ltd.	222MF10009	Heavy Magnesium Oxide JP	2010-01-07	2010-01-07	305 Yashima Nishimachi, Takamatsu City, Kagawa Prefecture
28/03/2025	Kyowa Hakko Bio	Japan	Kyowa Chemical Industry Co., Ltd.	222MF10008	Japanese Pharmacopoeia Magnesium Oxide (for manufacturi...	2010-01-07	2010-01-07	305 Yashima Nishimachi, Takamatsu City, Kagawa Prefecture

Magnesium Oxide

Magnesium Oxide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

14 USDMF

1 CEP/COS

15 JDMF

1 EU WC

2 KDMF

4 NDC API

7 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

44 FDF Dossiers

6 FDA Orange Book

3 Europe

5 Canada

21 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT

RELATED EXCIPIENT COMPANIES

2 EUROAPI

10 Rochem International Inc

19 SPI Pharma

24 DKSH

1 Pharm-RX Chemical

9 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

9 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

11 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

34 BASF

1 Bioplus Life Sciences

1 Clariant

11 Corel Pharma Chem

4 DFE Pharma

2 Finar

13 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

19 Kerry

5 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

11 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

41 Roquette

13 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

3 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 The Dow Chemical Company

2 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders

59 Coating Systems & Additives

46 Thickeners and Stabilizers

FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons